Works matching IS 00099236 AND DT 2020 AND VI 108 AND IP 4
Results: 29
In This Issue.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 108, n. 4, p. 689, doi. 10.1002/cpt.2002
- Publication type:
- Article
ASCPT News.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 108, n. 4, p. 693, doi. 10.1002/cpt.2001
- Publication type:
- Article
Highlights.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 108, n. 4, p. 691, doi. 10.1002/cpt.1988
- Publication type:
- Article
Tribute: Marcus M. Reidenberg, MD.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 108, n. 4, p. 697, doi. 10.1002/cpt.1940
- By:
- Publication type:
- Article
Challenges in Drug Development Posed by the COVID‐19 Pandemic: An Opportunity for Clinical Pharmacology.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 108, n. 4, p. 699, doi. 10.1002/cpt.1879
- By:
- Publication type:
- Article
Chronic Inhibition of CYP3A is Temporarily Reduced by Each Hemodialysis Session in Patients With End‐Stage Renal Disease.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 108, n. 4, p. 866, doi. 10.1002/cpt.1875
- By:
- Publication type:
- Article
Clinically Relevant Cytochrome P450 3A4 Induction Mechanisms and Drug Screening in Three‐Dimensional Spheroid Cultures of Primary Human Hepatocytes.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 108, n. 4, p. 844, doi. 10.1002/cpt.1860
- By:
- Publication type:
- Article
Clinical Trials for COVID‐19: Can we Better Use the Short Window of Opportunity?
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 108, n. 4, p. 730, doi. 10.1002/cpt.1891
- By:
- Publication type:
- Article
Pandemic Best Regulatory Practices: An Urgent Need in the COVID‐19 Pandemic.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 108, n. 4, p. 703, doi. 10.1002/cpt.1932
- By:
- Publication type:
- Article
The Approved Dose of Ivermectin Alone is not the Ideal Dose for the Treatment of COVID‐19.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 108, n. 4, p. 762, doi. 10.1002/cpt.1889
- By:
- Publication type:
- Article
UGT1A3 and Sex Are Major Determinants of Telmisartan Pharmacokinetics—A Comprehensive Pharmacogenomic Study.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 108, n. 4, p. 885, doi. 10.1002/cpt.1928
- By:
- Publication type:
- Article
Management of Osteoarthritis During the COVID‐19 Pandemic.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 108, n. 4, p. 719, doi. 10.1002/cpt.1910
- By:
- Publication type:
- Article
Prioritization of Anti‐SARS‐Cov‐2 Drug Repurposing Opportunities Based on Plasma and Target Site Concentrations Derived from their Established Human Pharmacokinetics.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 108, n. 4, p. 775, doi. 10.1002/cpt.1909
- By:
- Publication type:
- Article
Pregnane X Receptor Activator Rifampin Increases Blood Pressure and Stimulates Plasma Renin Activity.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 108, n. 4, p. 856, doi. 10.1002/cpt.1871
- By:
- Publication type:
- Article
Incidence of Adverse Drug Reactions in COVID‐19 Patients in China: An Active Monitoring Study by Hospital Pharmacovigilance System.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 108, n. 4, p. 791, doi. 10.1002/cpt.1866
- By:
- Publication type:
- Article
Creating E‐Labeling Platforms: An Industry Vision.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 108, n. 4, p. 716, doi. 10.1002/cpt.1865
- By:
- Publication type:
- Article
Using Healthcare Databases to Replicate Trial Findings for Supplemental Indications: Adalimumab in Patients with Ulcerative Colitis.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 108, n. 4, p. 874, doi. 10.1002/cpt.1861
- By:
- Publication type:
- Article
Finding the Dose for Hydroxychloroquine Prophylaxis for COVID‐19: The Desperate Search for Effectiveness.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 108, n. 4, p. 766, doi. 10.1002/cpt.1874
- By:
- Publication type:
- Article
Effects and Safety of Statin and Ezetimibe Combination Therapy in Patients with Chronic Kidney Disease: A Systematic Review and Meta‐Analysis.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 108, n. 4, p. 833, doi. 10.1002/cpt.1859
- By:
- Publication type:
- Article
Neuronavigation‐Guided rTMS for the Treatment of Depressive Patients With Suicidal Ideation: A Double‐Blind, Randomized, Sham‐Controlled Trial.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 108, n. 4, p. 826, doi. 10.1002/cpt.1858
- By:
- Publication type:
- Article
Higher Dosage of Ciprofloxacin Necessary in Critically Ill Patients: A New Dosing Algorithm Based on Renal Function and Pathogen Susceptibility.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 108, n. 4, p. 770, doi. 10.1002/cpt.1855
- By:
- Publication type:
- Article
Reweighting Randomized Controlled Trial Evidence to Better Reflect Real Life – A Case Study of the Innovative Medicines Initiative.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 108, n. 4, p. 817, doi. 10.1002/cpt.1854
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 108, n. 4, p. 681, doi. 10.1002/cpt.1526
- Publication type:
- Article
Response to Inhibition of Receptor‐Interacting Protein Kinase 1 (RIPK1) in Active Plaque Psoriasis: A Randomized Placebo‐Controlled Study.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 108, n. 4, p. 808, doi. 10.1002/cpt.1852
- By:
- Publication type:
- Article
Role of Guidance and Policy in Enhancing the Impact of Clinical Pharmacology in Drug Development, Regulation, and Use.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 108, n. 4, p. 710, doi. 10.1002/cpt.1849
- By:
- Publication type:
- Article
The Effects of Weak and Strong CYP3A Induction by Rifampicin on the Pharmacokinetics of Five Progestins and Ethinylestradiol Compared to Midazolam.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 108, n. 4, p. 798, doi. 10.1002/cpt.1848
- By:
- Publication type:
- Article
The Efficacy, Safety, and Immunogenicity of Switching Between Reference Biopharmaceuticals and Biosimilars: A Systematic Review.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 108, n. 4, p. 734, doi. 10.1002/cpt.1836
- By:
- Publication type:
- Article
The Use of Mobile Technology in Drug Development.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 108, n. 4, p. 706, doi. 10.1002/cpt.1815
- By:
- Publication type:
- Article
Leading a Digital Transformation in the Pharmaceutical Industry: Reimagining the Way We Work in Global Drug Development.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 108, n. 4, p. 756, doi. 10.1002/cpt.1850
- By:
- Publication type:
- Article